Once-daily Seroquel launched
September 18, 2008Sales and Marketing AZ, psych
AstraZeneca has launched a once-daily version of Seroquel in the UK. The drug is used to treat schizophrenia and manic …
Ban on ‘top-up’ payments for drugs not working
September 18, 2008Sales and Marketing NHS, par
The King's Fund says the current ban on NHS patients paying privately for 'top-up' drugs is not working. The Department …
Working Life: Amanda Moosa
September 18, 2008Business Services, Sales and Marketing Nycomed, Working Life, branding, careers, marketing, sales
How did you find your way into your current role?I came into things via the ‘traditional’ route. After my biochemistry …
The Pharmafocus Interview: Andrew Dillon
September 17, 2008Research and Development, Sales and Marketing NHS, NICE, hc
NICE's rejection of four new cancer drugs predictably provoked the ire of campaigners, again raising unfavourable comparisons with European uptake …
GSK seeks risk-sharing deal for Tyverb
September 17, 2008Sales and Marketing Cancer, GSK, NICE, par
GlaxoSmithKline has approached the government for a new pricing deal on its breast cancer drug Tyverb, which could make it …
PCTs told to explain how drug funding decisions are reached
September 17, 2008NHS, hc
The Department of Health has written to PCT chief executives requesting information on how they reach funding decisions on new …
GSK unveils new cancer unit
September 17, 2008Research and Development Cancer, GSK
GSK has unveiled a new integrated oncology R&D unit aimed at enhancing its presence in cancer care.The unit will be …
Amgen sells off two biotech products
September 16, 2008Research and Development biotech
Biotech pioneer Amgen has sold off two niche products to Biovitrum, along with the promotional rights to a third product, …
Latest news from Datamonitor
September 15, 2008Sales and Marketing NICE, rcc
UK watchdog's guidance knocks kidney cancer drugsThe UK's cost-effectiveness watchdog NICE has delivered another blow to the developers of targeted …
Lilly launches diabetes patient education programme
September 12, 2008Medical Communications, Sales and Marketing diabetes, patients
Lilly has launched an international diabetes education programme, the centrepiece of which is a tool for healthcare professionals to conduct …
Patient wins legal battle for Revlimid
September 12, 2008Sales and Marketing Cancer, Revlimid
A cancer patient has won access to cancer drug Revlimid in a court battle with his local PCT. West Sussex …
The potential and the perils of online recruitment
September 11, 2008Business Services careers, digi, recruitment
It's easy to be someone different on the internet – a recent conference on Second Life was attended by a …
Merck Serono takes lead role in antibody partnership
September 11, 2008Research and Development Merck Serono
Merck Serono has agreed to take on full responsibility for developing a promising antibody from its partner ZymoGenetics. The German …
Postcode lottery of care persists in England
September 11, 2008Sales and Marketing par
A new report identifies widespread variations in how much the NHS spends locally on different diseases. The King's Fund says …
Oxford BioMedica unsettled by chief executive’s departure
September 10, 2008Sales and Marketing Oxford BioMedica, biotech
Confidence has been shaken in Oxford BioMedica following news that its chief executive has stepped down just one month after …
Viehbacher leaves GSK for Sanofi
September 10, 2008Sales and Marketing GSK, Sanofi
Chris Viehbacher is set to leave GlaxoSmithKline for a lead role at Sanofi-Aventis after last year losing out to Andrew …
Government looks set to allow top-up fees
September 10, 2008Sales and Marketing Cancer, Karol Sikora, NICE
Patients in the UK could soon gain official clearance to pay ‘top up’ fees in order to receive the cancer …
Tapping into the audience’s imagination
September 9, 2008Medical Communications Best of Health, IPA, advertising, awards, event
Latest news from Datamonitor
September 9, 2008Sales and Marketing lifecycle
Drug lifecycle management could be the answer to the $100 billion questionGenerics are finding their way onto the drugs market …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
